Israel Cancer Research Fund announces $5.35 million in new grants
Israel Cancer Research Fund (ICRF) has announced $5.35 million in new cancer research grants for the 2026-27 funding year, supporting 38 research projects led by scientists at institutions across Israel. These new commitments are being supported by ICRF International/US, ICRF Israel and ICRF Toronto.The new awards bring ICRF’s lifetime investment to just under $109 million across more than 3,000 cancer research grants since 1975, supporting Israeli scientists whose discoveries have helped advance cancer research and improve patient care worldwide.With 57 additional renewing grants, ICRF will support 95 active research grants during the 2026-27 funding year, representing $5.84 million in research funding. The new awards represent a $7.25 million total multiyear investment.“Every grant we fund represents an investment in the scientists and ideas that can change the future of cancer,” said Alan Herman, ICRF executive director. “We are proud to support Israel’s extraordinary scientific community, from emerging researchers establishing their careers…
The Israel Cancer Research Fund (ICRF) has announced $5.35 million in new grants for the 2026-27 funding year, supporting 38 research projects by Israeli scientists. These grants, backed by ICRF International/US, ICRF Israel, and ICRF Toronto, bring ICRF's total investment to nearly $109 million across over 3,000 grants since 1975. The new awards are part of a $7.25 million total multiyear investment, with 57 additional renewing grants bringing the total active research grants to 95 for the funding year, representing $5.84 million. Alan Herman, ICRF executive director, stated, "Every grant we fund represents an investment in the scientists and ideas that can change the future of cancer." The grants support diverse research areas, including AI, advanced imaging, liquid biopsy, genomics, microbiome research, and immunotherapy, with notable projects including early cancer detection via MRI, in utero chemotherapy effects, and single-cell analysis for leukemia diagnosis.
© All rights to the original article belong to the source. Din Online shows a headline, an excerpt and a link only. The objectivity rating is computed automatically and is an estimate only.
Discussion
No comments yet — be the first to comment.